3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Thoracic
23
Lymphoid
9
Plasma cell
4
CNS
4
Other hematologic neoplasm
2
Genitourinary
2
Gastrointestinal
2
Tumor-Agnostic
1
Other solid neoplasm
1
Dermatologic
1
Breast
1
Interventions
Paclitaxel
151
Carboplatin
123
Bevacizumab
86
Cisplatin
66
pembrolizumab
58
Taxes
51
Gemcitabine
51
liposomal doxorubicin
38
Topotecan
37
olaparib
30
Immunoglobulin G
27
Disulfides
26
Cyclophosphamide
24
Brachytherapy
22
Docetaxel
21
human papillomavirus vaccine, L1 type 16, 18
20
Platinum
19
niraparib
18
1,2-diaminocyclohexaneplatinum II citrate
18
rucaparib
17
Nivolumab
17
Magnetic Resonance Spectroscopy
17
durvalumab
16
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
16
Doxorubicin
16
Radiotherapy, Intensity-Modulated
14
Radiation
13
Albumin-Bound Paclitaxel
13
fludarabine phosphate
12
fludarabine
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Crizotinib
×
Gynecologic
×
Clear all
No trials found.